Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
James, D.R.
Alfaham, M.
and
Goodchild, M.C.
1991.
Increased susceptibility to peroxide-induced haemolysis with normal vitamin E concentrations in cystic fibrosis.
Clinica Chimica Acta,
Vol. 204,
Issue. 1-3,
p.
279.
Mischler, Elaine H.
Marcus, Mary S.
Sondel, Sherie A.
Laxova, Anita
Carey, Patrick
Langhough, Rebecca
and
Farrell, Philip M.
1991.
Nutritional assessment of infants with cystic fibrosis diagnosed through screening.
Pediatric Pulmonology,
Vol. 11,
Issue. S7,
p.
56.
Dodge, John A.
1992.
Nutrition in cystic fibrosis: a historical overview.
Proceedings of the Nutrition Society,
Vol. 51,
Issue. 2,
p.
225.
Horrobin, D.F.
1992.
Nutritional and medical importance of gamma-linolenic acid.
Progress in Lipid Research,
Vol. 31,
Issue. 2,
p.
163.
Kurlandsky, Lawrence E.
Bennink, Maurice R.
Webb, Phyllis M.
Ulrich, Pamela J.
and
Baer, Lawrence J.
1994.
The absorption and effect of dietary supplementation with omega‐3 fatty acids on serum leukotriene B4, in patients with cystic fibrosis.
Pediatric Pulmonology,
Vol. 18,
Issue. 4,
p.
211.
Christophe, A. B.
Warwick, W. J.
and
Holman, R. T.
1994.
Serum fatty acid profiles in cystic fibrosis patients and their parents.
Lipids,
Vol. 29,
Issue. 8,
p.
569.
Dodge, J.A.
1994.
Dietary fat in cystic fibrosis.
The Journal of Pediatrics,
Vol. 125,
Issue. 5,
p.
844.
RETTAMMEL, AMY LYNN
MARCUS, MARY S.
FARRELL, PHILIP M.
SONDEL, SHERIE A.
KOSCIK, REBECCA E.
and
MISCHLER, ELAINE H.
1995.
Oral Supplementation with a High-Fat, High-Energy Product Improves Nutritional Status and Alters Serum Lipids in Patients with Cystic Fibrosis.
Journal of the American Dietetic Association,
Vol. 95,
Issue. 4,
p.
454.
Lepage, G
Champagne, J
Ronco, N
Lamarre, A
Osberg, I
Sokol, RJ
and
Roy, CC
1996.
Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis.
The American Journal of Clinical Nutrition,
Vol. 64,
Issue. 1,
p.
87.
Christophe, A.
and
Robberecht, E.
1996.
Current knowledge on fatty acids in cystic fibrosis.
Prostaglandins, Leukotrienes and Essential Fatty Acids,
Vol. 55,
Issue. 3,
p.
129.
Lepage, Guy
Paradis, Khazal
Lacaille, Florence
Sénéchal, Lyne
Ronco, Nancy
Champagne, Josée
Lenaerts, Catherine
Roy, Claude C.
and
Rasquin-Weber, Andrée
1997.
Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis.
The Journal of Pediatrics,
Vol. 130,
Issue. 1,
p.
52.
Colombo, Carla
Crosignani, Andrea
and
Battezzati, Pier Maria
1999.
Liver involvement in cystic fibrosis.
Journal of Hepatology,
Vol. 31,
Issue. 5,
p.
946.
Peretti, N
Marcil, V
Drouin, E
and
Levy, E
2005.
Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency.
Nutrition & Metabolism,
Vol. 2,
Issue. 1,
Jumpsen, Jacqueline A.
Brown, Neil E.
Thomson, Alan B.R.
Paul Man, S.F.
Goh, Yeow K.
Ma, David
and
Clandinin, M.T.
2006.
Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
Journal of Cystic Fibrosis,
Vol. 5,
Issue. 2,
p.
77.
Wheelock, Craig E.
and
Strandvik, Birgitta
2020.
Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms.
Prostaglandins, Leukotrienes and Essential Fatty Acids,
Vol. 160,
Issue. ,
p.
102156.
Strandvik, Birgitta
2021.
Is the ENaC Dysregulation in CF an Effect of Protein-Lipid Interaction in the Membranes?.
International Journal of Molecular Sciences,
Vol. 22,
Issue. 5,
p.
2739.
Strandvik, Birgitta
2022.
Nutrition in Cystic Fibrosis—Some Notes on the Fat Recommendations.
Nutrients,
Vol. 14,
Issue. 4,
p.
853.
Sharifi, Melika
Nourani, Nasim
Sanaie, Sarvin
and
Hamedeyazdan, Sanaz
2024.
The effect of Oenothera biennis (Evening primrose) oil on inflammatory diseases: a systematic review of clinical trials.
BMC Complementary Medicine and Therapies,
Vol. 24,
Issue. 1,